OS endpoint focus will realign industry to “ultimate goal”
While OS is still the king of the oncology endpoints, experts note it may soon be phased out due to the introduction of better, more advanced cancer therapies.
02 October 2025
02 October 2025
While OS is still the king of the oncology endpoints, experts note it may soon be phased out due to the introduction of better, more advanced cancer therapies.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.